novo nordisk semaglutide fda Novo's Wegovy adds another indication with approval Novo Nordisk withdraws FDA application

Most shots are 1000 mcg/mL

Many healthcare providers recommend pausing or carefully reassessing semaglutide use during this time , as further slowing digestion may worsen discomfort or delay recovery

Start at 1 mg

I can see higher-risk patients being more likely to have been given Tirzepetide, given the widely held perception that its a stronger medication if they were assessed to have greater risk and skewing the patient pool

Note that the costs, dosages, and approved uses are U.S.-based

They're a direct consequence of how semaglutide works: Delayed Gastric Emptying Food stays in your stomach longer, causing fullness and nausea